531 results on '"Saha, Vaskar"'
Search Results
2. Maintenance Treatment in Acute Lymphoblastic Leukemia: A Clinical Primer
3. How to write a research grant proposal
4. Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL
5. Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
6. Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India
7. Analysis toolkit for evaluation of drug titration practice in acute lymphoblastic leukemia maintenance.
8. Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia
9. Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial
10. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial
11. The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries
12. How to write a research grant proposal
13. Relapsed Acute Lymphoblastic Leukemia of Childhood
14. Development of EPAT: An assessment tool for pediatric hematology/oncology training programs
15. Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia
16. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
17. The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
18. The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries.
19. Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia.
20. Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017–2019
21. Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region
22. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia
23. Nucleoside Analogues
24. Identifying Targets for New Therapies in Children with Acute Lymphoblastic Leukemia
25. Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL
26. ALL-REZ BFM 2002 Is Associated with Improved Outcome as Compared to ALL-R3 Strategy in Children with Standard Risk Isolated CNS Relapse of Acute Lymphoblastic Leukemia, while Maintaining Comparable Efficacy in Patients with Bone Marrow Relapse. Results of the Multi-National, Multi-Center Trial IntReALL SR 2010
27. Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia
28. Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
29. IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALL
30. Computerised Advice on Drug Dosage Decisions in Childhood Leukaemia: A Method and a Safety Strategy
31. Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India.
32. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
33. Activity and toxicity of intramuscular 1000 iu /m 2 polyethylene glycol‐ E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials
34. Surveillance and caregiver vaccination prevent varicella outbreaks in a residential care facility for children with cancer
35. Unique mutation and gene expression in High Hyperdiploid Acute Lymphoblastic Leukaemia with whole chromosome uniparental isodisomy
36. Additional file 1 of Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India
37. RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia
38. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
39. Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity
40. Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia
41. Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata
42. Superior Overall Survival with Blinatumomab Versus Chemotherapy As Pre-Transplant Consolidation Treatment in Children with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL): Longer Follow-up (FU) of a Phase 3 Randomized Controlled Trial (RCT)
43. Complex Genomic Alterations and Gene Expression in Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21
44. Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia.
45. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
46. Reply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India—Implications for clinical outcomes in acute lymphoblastic leukaemia
47. IntReALL HR and the benefits of adaptive design
48. The Leukemia-Associated-Protein (LAP) Domain, a Cysteine-Rich Motif, is Present in a Wide Range of Proteins, Including MLL, AF10, and MLLT6 Proteins
49. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials
50. Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.